We recommend that you upgrade to the latest version of your browser.

MRCRM "How to" series - 2024/2025

This semester, we are introducing a new seminar series concept called “How to” - a format that encourages speakers to share their knowledge and expertise so that others can learn from it.

1.
April
2025
  1. 01. Apr 2025, 2:30 PM - 3:30 PM

Time and place

When

  1. 01. Apr 2025, 2:30 PM - 3:30 PM

Organizer

Mohn Research Centre for Regenerative Medicine (MRCRM)

Where

TBA

April 1: "How to.." seminar with Dr. Novin Balakan

 

December 10: Christmas symposium

 

October 1: Professor Anna Pasetto

The topic is pre-GMP - how to translate your research protocol of ATMPs to a Good Manufacturing Practice (GMP) compliant production protocol. 

More information will come, but if you have specific pre-GMP related questions or  challenges you wish Prof. Pasetto to cover, please send an email to: MRCRM@helse-bergen.no.

 

Speaker

Anna Pasetto, PhD

Anna Pasetto
Prof. Anna Pasetto

Director of the Center for Advanced Cell Therapy (ACT), Section for Cell Therapy, Division for Cancer Treatment, Cancer Clinic, Oslo University Hospital

Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo

Dr. Pasetto joined the Oslo University Hospital in 2022 as Director of the Center for Advanced Cell Therapy (ACT) and she is also Associate Professor at the University of Oslo. Since 2018, she worked at the Karolinska Institutet as Assistant Professor and Managing Director of the pre-GMP facility in the Department of Laboratory Medicine, where she is still affiliated to this day as research specialist.
She received her Master Degree in Molecular Biotechnology in 2007 from Alma Mater Studiorum Bologna University, Italy. Then she moved to the Karolinska Institutet where she received her PhD in 2012. Pasetto joined the laboratory of Dr. Steven Rosenberg as post-doctoral fellow at the National Cancer Institute, NIH in 2013 and her research was focused on the isolation of TCR genes from mutation-reactive tumor infiltrating lymphocytes in metastatic solid cancers. 
Her professional goals is to facilitate and support the development of new immunotherapies against cancer.

 

August 20: Professor Simona Chera

Simona Chera

Photo: Simona Chera

Prof. Simona Chera

Our first speaker is Professor Simona Chera at the Department of Clincial Science, University of Bergen. She will share her expertise on human induced pluripotent stem cells (hiPSCs). 

Title:

How to harness human induced pluripotent stem cells for beta cell generation

About the speaker:

Simona Chera is a Professor at the Department of Clinical Science at the University of Bergen and a principal investigator in the Center for Diabetes Research. She is an expert in cell fate decisions, islet cell plasticity, and molecular networks.

 

Contact